A Study of Atezolizumab in Participants With Locally Advanced or Metastatic Urothelial Bladder Cancer (Cohort 2)
Clinical trial NCT02108652 · COMPLETED
Trial details
- NCT number
- NCT02108652
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-31
- Primary completion
- 2016-07-04
- Enrollment
- 310
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.